Genesis Biopharma has named David Voyticky to its board of directors. Voyticky is currently president of Miller Energy Resources, an oil and gas exploration company, and has more than 16 years of experience in corporate finance and merger and acquisition consulting.
The Genesis Biopharma board now consists of six members, including four independent directors.
"David's experience in guiding high-growth companies will help us effectively manage our current opportunities," said Anthony J. Cataldo, chairman and CEO of Genesis Biopharma. "In addition, as the company is poised to be a leader in developing new cancer therapies, David's background and expertise in corporate finance and strategic transactions will play an important role in building long-term value."